ICM
ABBV icon

IronBridge Capital Management’s AbbVie ABBV Stock Holding History

IronBridge Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,950
Closed -$758K – 181
2015
Q1 		$758K Sell
12,950
-1,038,075
-99% -$62.7M 0.02% 172
2014
Q4 		$68.8M Sell
1,051,025
-134,230
-11% -$8.46M 1.92% 11
2014
Q3 		$68.5M Buy
1,185,255
+120,805
+11% +$6.71M 1.82% 14
2014
Q2 		$60.1M Buy
+1,064,450
New +$55.8M 1.47% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

IronBridge Capital Management's ABBV Position: Q2 2015 in Review

IronBridge Capital Management sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 12,950 shares — an estimated $758K sold.

IronBridge Capital Management first reported a position in ABBV in Q2 2014 and held it in 4 quarters. The position peaked at $68.8M in Q4 2014. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • IronBridge Capital Management reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • IronBridge Capital Management sold 12,950 AbbVie shares in Q2 2015, an estimated $758K.
  • IronBridge Capital Management first reported a position in AbbVie in Q2 2014 and held it in 4 quarters.
  • IronBridge Capital Management's AbbVie position peaked at $68.8M in Q4 2014.
  • 1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on IronBridge Capital Management's 13F filing for Q2 2015, filed 10 Aug 2015.